Steroid-Functionalized Imidazolium Salts with an Extended Spectrum of Antifungal and Antibacterial Activity.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Nov 2021
Historique:
received: 30 09 2021
revised: 03 11 2021
accepted: 08 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 20 1 2022
Statut: epublish

Résumé

It is established that high rates of morbidity and mortality caused by fungal infections are related to the current limited number of antifungal drugs and the toxicity of these agents. Imidazolium salts as azole derivatives can be successfully used in the treatment of fungal infections in humans. Steroid-functionalized imidazolium salts were synthesized using a new, more efficient method. As a result, 20 salts were obtained with high yields, 12 of which were synthesized and characterized for the first time. They were derivatives of lithocholic acid and 3-oxo-23,24-dinorchol-4-ene-22-al and were fully characterized by

Identifiants

pubmed: 34830061
pii: ijms222212180
doi: 10.3390/ijms222212180
pmc: PMC8623970
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antifungal Agents 0
Imidazoles 0
Salts 0
Steroids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Antimicrob Chemother. 2009 Feb;63(2):343-8
pubmed: 19109335
Chem Soc Rev. 2013 Dec 7;42(23):9055-70
pubmed: 23979404
Front Microbiol. 2015 Jul 03;6:669
pubmed: 26191055
Cold Spring Harb Perspect Med. 2014 May 01;4(5):
pubmed: 24789878
J Phys Chem B. 2020 May 14;124(19):3909-3921
pubmed: 32302476
Antibiotics (Basel). 2020 Jul 25;9(8):
pubmed: 32722455
FEBS Lett. 1978 Jul 1;91(1):140-3
pubmed: 668904
Biol Proced Online. 2004;6:220-225
pubmed: 15472722
Infect Control Hosp Epidemiol. 2015 Nov;36(11):1298-304
pubmed: 26310725
J Appl Microbiol. 2016 Aug;121(2):445-52
pubmed: 26972421
Sci Rep. 2019 Jan 18;9(1):218
pubmed: 30659217
Front Microbiol. 2017 Jan 12;7:2173
pubmed: 28127295
Infect Immun. 2015 Feb;83(2):604-13
pubmed: 25422264
Chem Sci. 2020 Aug 11;11(39):10605-10613
pubmed: 34094315
Bioorg Med Chem Lett. 2015 Sep 1;25(17):3601-5
pubmed: 26174555
J Med Chem. 2013 Feb 28;56(4):1596-613
pubmed: 23327489
J Funct Biomater. 2014 May 08;5(2):43-57
pubmed: 24956439
Biomed Rep. 2015 Sep;3(5):617-620
pubmed: 26405534
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28784671
Acta Pharm Sin B. 2017 Mar;7(2):119-136
pubmed: 28303218
Acc Chem Res. 2006 Dec;39(12):935-44
pubmed: 17176032
Sci Rep. 2015 May 18;5:9761
pubmed: 25985150
Curr Opin Microbiol. 2010 Aug;13(4):389-91
pubmed: 20558099
ChemMedChem. 2018 May 23;13(10):1004-1017
pubmed: 29512892
Metallomics. 2012 Jan;4(1):23-32
pubmed: 22027962
Recent Pat Antiinfect Drug Discov. 2007 Nov;2(3):182-7
pubmed: 18221175
Chem Rev. 2011 Apr 13;111(4):2705-33
pubmed: 21235210
Clin Microbiol Infect. 2018 Jun;24(6):591-598
pubmed: 29138100
J Steroid Biochem Mol Biol. 2019 May;189:65-72
pubmed: 30797035
Pathogens. 2019 May 21;8(2):
pubmed: 31117285
Chem Rev. 2009 Aug;109(8):3859-84
pubmed: 19580262
Bioorg Chem. 2021 Mar;108:104550
pubmed: 33353805

Auteurs

Marta Malinowska (M)

Department of Organic Chemistry, Faculty of Chemistry, University of Bialystok, Ciołkowskiego, 1K, 15-245 Białystok, Poland.

Diana Sawicka (D)

Department of Experimental Pharmacology, Faculty of Health Sciences, Medical University of Bialystok, Szpitalna, 37, 15-295 Białystok, Poland.

Katarzyna Niemirowicz-Laskowska (K)

Department of Experimental Pharmacology, Faculty of Health Sciences, Medical University of Bialystok, Szpitalna, 37, 15-295 Białystok, Poland.

Przemysław Wielgat (P)

Department of Clinical Pharmacology, Faculty of Medicine with the Division of Dentistry and Division of Medical Education in English, Medical University of Bialystok, Waszyngtona, 15A, 15-274 Białystok, Poland.

Halina Car (H)

Department of Experimental Pharmacology, Faculty of Health Sciences, Medical University of Bialystok, Szpitalna, 37, 15-295 Białystok, Poland.

Tomasz Hauschild (T)

Department of Microbiology and Biotechnology, Faculty of Biology, University of Bialystok, Ciołkowskiego, 1J, 15-245 Białystok, Poland.

Agnieszka Hryniewicka (A)

Department of Organic Chemistry, Faculty of Chemistry, University of Bialystok, Ciołkowskiego, 1K, 15-245 Białystok, Poland.
Department of Organic Chemistry, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza, 2A, 15-222 Bialystok, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH